A novel antidiabetic drug, troglitazone--reason for hope and concern

N Engl J Med. 1998 Mar 26;338(13):908-9. doi: 10.1056/NEJM199803263381311.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Administration, Oral
  • Chemical and Drug Induced Liver Injury
  • Chromans / adverse effects
  • Chromans / therapeutic use*
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Humans
  • Hypoglycemic Agents / adverse effects
  • Hypoglycemic Agents / therapeutic use*
  • Thiazoles / adverse effects
  • Thiazoles / therapeutic use*
  • Thiazolidinediones*
  • Troglitazone

Substances

  • Chromans
  • Hypoglycemic Agents
  • Thiazoles
  • Thiazolidinediones
  • Troglitazone